Search

everythinglearnresearchcommunity

for

Search:↓

Croton tiglium application significantly improved hair regrowth in alopecia areata patients.

Alopecia areata is a hair loss condition that often starts before age 30 and can affect various body parts, with unpredictable hair regrowth chances.

A man's red tattoo caused a skin reaction and hair loss in his beard, which improved after treatment.

Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.

Alopecia areata treatment varies, with no optimal method established yet.

How bad a woman's hair loss is doesn't always match how it affects her happiness and daily life.

Large doses of glucocorticoids are not suitable for general use in treating severe alopecia areata due to inconsistent results and risks.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

Both androgenetic alopecia and alopecia areata negatively impact quality of life, with no significant difference between them.

Researchers created a fast, accurate computer program to measure hair loss in alopecia areata patients.

The monkey's hair loss was due to an autoimmune disease, not genetics.

Alopecia areata leads to significantly higher healthcare costs due to more doctor visits and prescriptions.

Trichoscopy is useful for diagnosing and monitoring alopecia areata treatment.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

DKK-1 gene linked to hair loss in AGA and AA patients; more research needed for potential therapy.

Nonsteroid treatments for alopecia areata show promise but need more high-quality research.

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.

A 3-year-old boy lost all his hair due to a rare reaction to phenobarbital, but it grew back after steroid treatment.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

People with alopecia areata have higher levels of RBP4 protein and antibodies against it.

The Alopecia Areata Assessment Tool (ALTO) effectively identifies alopecia areata from other hair loss types but needs more validation.

Injecting platelet-rich plasma or applying it with a laser or microneedling can treat hair loss effectively. The laser and microneedling methods cause less pain.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Alopecia areata can sometimes appear as a straight line of hair loss instead of round patches.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

A child's hair loss from alopecia areata was fully reversed in five months using diet and supplements.

Biopsy can differentiate between alopecia areata and androgenic alopecia, and if more information is needed, testing for CD3 and CD8 can help.